MedPath

CKD-349

Generic Name
CKD-349

Study to Evaluate the Safety and Pharmacokinetics of CKD-349 in Healthy Adult Volunteers

Phase 1
Completed
Conditions
Chronic Heart Failure
Interventions
Drug: D113
First Posted Date
2021-10-22
Last Posted Date
2022-10-07
Lead Sponsor
Chong Kun Dang Pharmaceutical
Target Recruit Count
71
Registration Number
NCT05089279
Locations
🇰🇷

H Plus Yangji Hospital, Seoul, Gwanak-gu, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath